<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Free radical induced neuronal damage is implicated in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion (IR) injury and <z:chebi fb="11" ids="22586">antioxidants</z:chebi> are reported to have neuroprotective activity </plain></SENT>
<SENT sid="1" pm="."><plain>Several in vitro and in vivo studies have proved the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potential of <z:chebi fb="0" ids="3962">curcumin</z:chebi> and its metabolites </plain></SENT>
<SENT sid="2" pm="."><plain>Hence, in the present study the neuroprotective potential of <z:chebi fb="0" ids="3962">curcumin</z:chebi> was investigated in middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) induced focal cerebral IR injury </plain></SENT>
<SENT sid="3" pm="."><plain>2 h of MCAO and 22 h of reperfusion resulted in the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume of 210.39 +/- 31.25 mm3 </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of <z:chebi fb="0" ids="3962">curcumin</z:chebi> 100 and 300 mg/kg, i.p </plain></SENT>
<SENT sid="5" pm="."><plain>30 min. after MCAO produced 37.23 +/- 5.10% and 46.39 +/- 10.23% (p &lt; 0.05) reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, respectively </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> induced <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> was reduced in a dose dependent manner </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi> at 300 mg/kg, i.p. produced 50.96 +/- 6.04% reduction in <z:hpo ids='HP_0000969'>edema</z:hpo> (p &lt; 0.05) volume </plain></SENT>
<SENT sid="8" pm="."><plain>Increase in <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation after MCAO in ipsilateral and contralateral hemisphere of brain was observed, which was reduced by <z:chebi fb="0" ids="3962">curcumin</z:chebi> (300 mg/kg, i.p.)-treatment </plain></SENT>
<SENT sid="9" pm="."><plain>Decrease in <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase activity was observed in ipsilateral hemisphere of MCAO animal </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>-treatment (300 mg/kg, i.p.) prevented IR injury mediated fall in <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:chebi fb="39" ids="44785">peroxide</z:chebi> activity </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="25941">Peroxynitrite</z:chebi> measured using <z:chebi fb="0" ids="8828">rhodamine123</z:chebi> fluorescence and anti-nitrotyrosine immunofluorescence indicated increased <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi> formation after IR insult </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="3962">Curcumin</z:chebi>-treatment reduced <z:chebi fb="0" ids="25941">peroxynitrite</z:chebi> formation and hence the extent of tyrosine nitration in the cytosolic proteins </plain></SENT>
<SENT sid="13" pm="."><plain>These results suggest the neuroprotective potential of <z:chebi fb="0" ids="3962">curcumin</z:chebi> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and is mediated through its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity </plain></SENT>
</text></document>